| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |